Integration of Large-Scale Chromatography with Nanofiltration for an Ovine Polyclonal Product - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Integration of Large-Scale Chromatography with Nanofiltration for an Ovine Polyclonal Product
The authors examine the challenges of integrating a large-scale chromatography and nanofiltration process for purification of a polyclonal antibody.


Pharmaceutical Technology
Volume 33, Issue 1, pp. 62-70

References

1. K. DiBlasi et al., "Disposable Biopharmaceutical Processes, Myth or Reality?," BioPharm Int., Nov. 2006 supplement, 6–16.

2. R. Francis, "Efficient Process Development Strategies Can Translate into Robust Large-Scale Manufacturing," presented at the IBC Conference, San Francisco, Nov. 2006.

3. C. Jones and A. Denton, "Integration of Large Scale Chromatography with Nanofiltration for an Ovine Polyclonal Product," presented at the European Downstream Technology Forum, Sartorius College, Goettingen, Germany, May 2007.

4. K. Tarrach et al., "The Effect of Flux Decay on a 20-nm Nanofilter for Virus Retention," BioPharm Int., April, 58–63, 2007.

5. K. Tarrach, "Integrative Strategies for Viral Clearance," presented at the 4th Annual Biological Production Forum, Edinburgh, Apr. 2005.

6. K. Brorson, "Virus Filter Validation and Performance," presented at the Recovery of Biological Products XII conference, Phoenix, AZ, Apr. 2006.

7. EMEA/CPMP, Note for Guidance on Virus Validation Studies: The Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses (London, Feb. 1996), available at http://www.emea.europa.eu/pdfs/human/bwp/026895en.pdf. accessed on Dec. 19, 2008.

8. ICH and FDA, Q5A Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (Geneva, Switzerland and Rockville, MD, Sept. 1998).

9. M. Cabatingan, "Impact of Virus Stock Quality on Virus Filter Validation, A Case Study," BioProcess Int., Nov. 2005 supplement, 39–43.

10. T. Ireland et al., "Viral Filtration of Plasma-Derived Human IgG: A Case Study Using Viresolve NFP," BioPharm Int. 17 (11), 38–44 (2004).

11. A. Higuchi et al., "Effect of Aggregated Protein Sizes on the Flux of Protein Solution Through Microporous Membranes." J. Membrane Sci. 236 (1–2), 137–144 (2004).

12. K. Tarrach, "Virus Filter Positioning in the Purification Process of Cell Culture Intermediates and Flow Decay Aspects Associated with Small Non-Enveloped Virus Retention," presented at the BioProcess International European Conference and Exhibition, Paris, Apr. 2007.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here